Literature DB >> 20678300

Can the CAMCOG be a good cognitive test for patients with Alzheimer's disease with low levels of education?

Ivan Aprahamian1, José Eduardo Martinelli, Juliana Cecato, Rafael Izbicki, Mônica Sanches Yassuda.   

Abstract

BACKGROUND: The Cambridge Cognitive Examination (CAMCOG) is a useful test in screening for Alzheimer's disease (AD). However, the interpretation of CAMCOG cut-off scores is problematic and reference values are needed for different educational strata. Given the importance of earlier diagnoses of mild dementia, new cut-off values are required which take into account patients with low levels of education. This study aims to evaluate whether the CAMCOG can be used as an accurate screening test among AD patients and normal controls with different educational levels.
METHODS: Cross-sectional assessment was undertaken of 113 AD and 208 elderly controls with heterogeneous educational levels (group 1: 1-4 years; group 2: 5-8 years; and group 3: ≥ 9 years) from a geriatric clinic. submitted to a thorough diagnostic evaluation for AD including the Cambridge Examination for Mental Disorders of the Elderly (CAMDEX). Controls had no cognitive or mood complaints. Sensitivity (SE) and specificity (SP) for the CAMCOG in each educational group was assessed with receiver-operator-characteristic (ROC) curves.
RESULTS: CAMCOG mean values were lower when education was reduced in both diagnostic groups (controls - group 1: 87; group 2: 91; group 3: 96; AD - group 1: 63; group 2: 62; group 3: 77). Cut-off scores for the three education groups were 79, 80 and 90, respectively. SE and SP varied among the groups (group 1: 88.1% and 83.5%; group 2: 84.6% and 96%; group 3: 70.8% and 90%).
CONCLUSION: The CAMCOG can be used as a cognitive test for patients with low educational level with good accuracy. Patients with higher education showed lower scores than previously reported.

Entities:  

Mesh:

Year:  2010        PMID: 20678300     DOI: 10.1017/S104161021000116X

Source DB:  PubMed          Journal:  Int Psychogeriatr        ISSN: 1041-6102            Impact factor:   3.878


  5 in total

Review 1.  Applications of technology in neuropsychological assessment.

Authors:  Carolyn M Parsey; Maureen Schmitter-Edgecombe
Journal:  Clin Neuropsychol       Date:  2013-09-16       Impact factor: 3.535

2.  Comparison of the diagnostic accuracy of neuropsychological tests in differentiating Alzheimer's disease from mild cognitive impairment: can the montreal cognitive assessment be better than the cambridge cognitive examination?

Authors:  José Eduardo Martinelli; Juliana Francisca Cecato; Daniel Bartholomeu; José Maria Montiel
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2014-05-20

3.  Assessment for apraxia in mild cognitive impairment and Alzheimer's dise.

Authors:  Mirela Ward; Juliana F Cecato; Ivan Aprahamian; José Eduardo Martinelli
Journal:  Dement Neuropsychol       Date:  2015 Jan-Mar

4.  Verbal behavior in Alzheimer's disease patients: Analysis of phrase repetition.

Authors:  Juliana Francisca Cecato; José Eduardo Martinellil; Luana Luz Bartholomeu; Ana Paula Basqueira; Mônica Sanches Yassuda; Ivan Aprahamian
Journal:  Dement Neuropsychol       Date:  2010 Jul-Sep

5.  Cognitive screening test in primary care: cut points for low education.

Authors:  Juliana Emy Yokomizo; Katrin Seeher; Glaucia Martins de Oliveira; Laís Dos Santos Vinholi E Silva; Laura Saran; Henry Brodaty; Ivan Aprahamian; Monica Sanches Yassuda; Cássio Machado de Campos Bottino
Journal:  Rev Saude Publica       Date:  2018-11-23       Impact factor: 2.106

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.